| 1 | journal of contemporary medical | | | | | | | 2 | 0.30% |
| 2 | skip to main content | | | | | | | 1 | 0.15% |
| 3 | ameer m al khafajiahsan | | | | | | | 1 | 0.15% |
| 4 | potential marker of disease | | | | | | | 1 | 0.15% |
| 5 | a potential marker of | | | | | | | 1 | 0.15% |
| 6 | sle a potential marker | | | | | | | 1 | 0.15% |
| 7 | in sle a potential | | | | | | | 1 | 0.15% |
| 8 | c in sle a | | | | | | | 1 | 0.15% |
| 9 | cystatin c in sle | | | | | | | 1 | 0.15% |
| 10 | serum cystatin c in | | | | | | | 1 | 0.15% |
| 11 | pdf clinical significance of | | | | | | | 1 | 0.15% |
| 12 | bairam pdf clinical significance | | | | | | | 1 | 0.15% |
| 13 | f bairam pdf clinical | | | | | | | 1 | 0.15% |
| 14 | khafajiahsan f bairam pdf | | | | | | | 1 | 0.15% |
| 15 | al khafajiahsan f bairam | | | | | | | 1 | 0.15% |
| 16 | m al khafajiahsan f | | | | | | | 1 | 0.15% |
| 17 | study ameer m al | | | | | | | 1 | 0.15% |
| 18 | of disease damage beyond | | | | | | | 1 | 0.15% |
| 19 | apoptotic activity of sitagliptin | | | | | | | 1 | 0.15% |
| 20 | hail saudi arabia rakesh | | | | | | | 1 | 0.15% |
| 21 | saudi arabia rakesh kumar | | | | | | | 1 | 0.15% |
| 22 | pdf synergistic antitumor and | | | | | | | 1 | 0.15% |
| 23 | synergistic antitumor and apoptotic | | | | | | | 1 | 0.15% |
| 24 | antitumor and apoptotic activity | | | | | | | 1 | 0.15% |
| 25 | and apoptotic activity of | | | | | | | 1 | 0.15% |
| 26 | activity of sitagliptin or | | | | | | | 1 | 0.15% |
| 27 | cancer cells an invitro | | | | | | | 1 | 0.15% |
| 28 | linagliptin plus cisplatin against | | | | | | | 1 | 0.15% |
| 29 | plus cisplatin against a549 | | | | | | | 1 | 0.15% |
| 30 | cisplatin against a549 lung | | | | | | | 1 | 0.15% |
| 31 | against a549 lung cancer | | | | | | | 1 | 0.15% |
| 32 | a549 lung cancer cells | | | | | | | 1 | 0.15% |
| 33 | lung cancer cells an | | | | | | | 1 | 0.15% |
| 34 | marker of disease damage | | | | | | | 1 | 0.15% |
| 35 | nephritis ibtisam jali pdf | | | | | | | 1 | 0.15% |
| 36 | lupus nephritis ibtisam jali | | | | | | | 1 | 0.15% |
| 37 | children investigating the cntnap2 | | | | | | | 1 | 0.15% |
| 38 | diabetes and hyperuricemia in | | | | | | | 1 | 0.15% |
| 39 | between diabetes and hyperuricemia | | | | | | | 1 | 0.15% |
| 40 | relationship between diabetes and | | | | | | | 1 | 0.15% |